Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$230.71 - $256.74 $53,294 - $59,306
-231 Reduced 6.81%
3,160 $768,000
Q1 2022

Apr 18, 2022

BUY
$219.27 - $242.57 $68,412 - $75,681
312 Added 10.13%
3,391 $820,000
Q4 2021

Jan 19, 2022

SELL
$198.88 - $227.6 $22,274 - $25,491
-112 Reduced 3.51%
3,079 $692,000
Q3 2021

Oct 22, 2021

SELL
$212.27 - $248.7 $43,515 - $50,983
-205 Reduced 6.04%
3,191 $679,000
Q2 2021

Aug 09, 2021

SELL
$233.58 - $259.14 $49,285 - $54,678
-211 Reduced 5.85%
3,396 $828,000
Q1 2021

May 05, 2021

BUY
$221.91 - $258.6 $86,544 - $100,854
390 Added 12.12%
3,607 $898,000
Q4 2020

Feb 09, 2021

BUY
$216.38 - $257.67 $80,060 - $95,337
370 Added 13.0%
3,217 $740,000
Q3 2020

Oct 23, 2020

BUY
$234.65 - $260.95 $4,458 - $4,958
19 Added 0.67%
2,847 $724,000
Q2 2020

Jul 31, 2020

SELL
$197.81 - $242.74 $9,099 - $11,166
-46 Reduced 1.6%
2,828 $667,000
Q1 2020

May 11, 2020

BUY
$182.24 - $241.7 $73,989 - $98,130
406 Added 16.45%
2,874 $583,000
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $3,973 - $5,107
21 Added 0.86%
2,468 $595,000
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $40,219 - $48,191
-231 Reduced 8.63%
2,447 $474,000
Q2 2019

Aug 06, 2019

SELL
$166.7 - $195.41 $4,334 - $5,080
-26 Reduced 0.96%
2,678 $493,000
Q4 2018

Feb 08, 2019

BUY
$178.4 - $208.25 $2,140 - $2,499
12 Added 0.45%
2,704 $527,000
Q3 2018

Nov 06, 2018

BUY
$185.29 - $208.89 $498,800 - $562,331
2,692 New
2,692 $558,000
Q2 2018

Aug 07, 2018

SELL
$166.05 - $186.51 $488,685 - $548,898
-2,943 Closed
0 $0
Q1 2018

May 04, 2018

SELL
$169.43 - $198.0 $13,893 - $16,236
-82 Reduced 2.71%
2,943 $502,000
Q4 2017

Feb 02, 2018

SELL
$168.79 - $188.59 $10,296 - $11,503
-61 Reduced 1.98%
3,025 $526,000
Q3 2017

Oct 27, 2017

BUY
$167.29 - $191.0 $516,256 - $589,426
3,086
3,086 $575,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cadence Bank Na Portfolio

Follow Cadence Bank Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank Na with notifications on news.